Introduction

The Indian Pharmaceutical Alliance (IPA) is an association of 23 leading research-based pharmaceutical companies in India, committed to patient care globally. IPA strives to create a collaborative environment for the Indian pharma industry to discover, develop and deliver quality-assured medicines equitably.

IPA began its journey in August 1999 with six top drug makers - Cipla, Dr Reddy’s, Lupin, Piramal, Ranbaxy and Wockhardt - as its founding members. Growing from strength to strength IPA has evolved as the most potent voice for the Indian pharma industry, promoting high standards in pharmaceutical production and quality assurance.

IPA member companies now collectively account for:

85%
of the private sector
investment in
pharmaceutical R&D
80%
of India's exports
of drugs &
pharmaceuticals
62%
of price-controlled
medicines
64%
of the domestic
market sales